Iain Ross

lain Ross joined as our Chairman in April 2019 and serves as Chair of our Nomination Committee. Mr. Rosss previously served as our Chairman between 2004 and 2010.

lain Ross has over 40 years of experience in the international life sciences and technology sectors and has held significant roles in multi-national companies including Sandoz, Hoffman La Roche, Reed Business Publishing, and Celltech Group plc. He has completed multiple financing transactions and has over 30 years of experience in cross-border management as a chairman and CEO. He has led and participated in seven Initial Public Offerings (POs) and has direct experience of M&A transactions in Europe, the USA, and the Pacific Rim. Currently, he is the non-executive chairman of Kazia Therapeutics Limited (ASX and Nasdaq) and formerly at Redx Pharma plc (LSE) and was responsible for leading the turnaround of both these companies before appointing new management. In addition, he is a non-executive director of Palla Pharma Limited (ASX) and advises a number of private companies in the biotechnology sector. He is a qualified Chartered Director and former Vice Chairman of the Council of Royal Holloway, London University.